Quantcast
Channel: GenomeWeb - Invitae
Browsing all 64 articles
Browse latest View live
↧

In Brief This Week: Invitae, Personalis, Seegene, Precipio, SkylineDx, and More

View Article


Singular Bio Technology Offers Invitae Route to Low-Cost Testing

View Article


Invitae Acquiring Jungla for up to $65M to Enhance Variant Interpretation

View Article

Invitae Reflects on Consumer-Initiated Test Pilot, Plans Improvements to...

View Article

Illumina Stock Stumbles in July as GenomeWeb Index Sinks 3 Percent

View Article


Invitae Q2 Revenues Increase 43 Percent

View Article

Stakeholders Voice Concerns, Push Back on NCD for NGS Cancer Panels

View Article

Concert Genetics Launches Software to Limit Coding Variability in Genetic...

View Article


Invitae Selling $300M in Convertible Notes

View Article


GenomeWeb Index Newcomers Adaptive Bio, Castle Biosciences See Steep Share...

View Article

CMS Proposes New National Coverage Policy for NGS Germline Testing

View Article

Castle Biosciences Stock Climbs in October, Clawing Back September Losses

View Article

U of Vermont Health Network Launches DNA Risk Screening Pilot Program

View Article


Invitae Q3 Revenues Grow 51 Percent

View Article

Some Call for Expanded Payor Coverage of NIPS but Reluctance Remains

View Article


Invitae to Acquire Genetic Counseling Chatbot Developer for $50M

View Article

In Brief This Week: Invitae, Thermo Fisher, PerkinElmer, More

View Article


Qiagen Stock Soars in November on Acquisition Speculation, Helping Push...

View Article

Invitae, BioMarin Partner on Access to Genetic Testing for Skeletal Dysplasias

View Article

Universal Genetic Testing in Breast Cancer May Result in More Harm Than Good,...

View Article
Browsing all 64 articles
Browse latest View live